BioScale Harvard Case Solution & Analysis

In 2004, Mark Lundstrom must decide on the method of financing and strategic approach to BioScale, a biotechnology company he founded. BioScale developed a microchip-based bioanalytical platform which can be used to detect very low concentrations of cells, viruses, proteins or small molecules. The company has several multi-billion dollar market in their sights. Up to this point, Lundstrom used a combination of individual and angel capital funding and government subsidies to meet the company's capital needs. Now he must decide whether to continue on its current "go slow to go fast strategy" or, conversely, to raise a significant round of capital or find a strategic partner. Lundstrom also explored career as an entrepreneur in the scientific and business. "Hide
by H. Kent Bowen, Bradley R. Staats Source: Harvard Business School 24 pages. Publication Date: June 21, 2006. Prod. #: 606100-PDF-ENG

Share This

SALE SALE

Save Up To

30%

IN ONLINE CASE STUDY

FOR FREE CASES AND PROJECTS INCLUDING EXCITING DEALS PLEASE REGISTER YOURSELF !!

Register now and save up to 30%.